• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌射频消融术后肺转移瘤切除术

Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma.

作者信息

Osuga Takahiro, Tanaka Shingo, Kubo Tomohiro, Hamaguchi Kota, Ito Ryo, Sakurada Akira, Ishikawa Keidai, Miyanishi Koji

机构信息

Department of Medical Oncology, Sapporo Medical University School of Medicine, Hokkaido, Japan.

Department of Infection Control and Laboratory Medicine, Sapporo Medical University School of Medicine, Hokkaido, Japan.

出版信息

Case Rep Oncol. 2024 Mar 1;17(1):407-416. doi: 10.1159/000536498. eCollection 2024 Jan-Dec.

DOI:10.1159/000536498
PMID:38435446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10907002/
Abstract

INTRODUCTION

Single distant metastases after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) are rare. There are no guidelines for treating patients without liver tumors after resecting lung metastases.

CASE PRESENTATION

Here, we report a patient with HCC recurring as a single lung metastasis 14 months after RFA. A 76-year-old woman with primary biliary cholangitis without hepatitis B virus or hepatitis C virus infection had been treated by RFA for a single 16-mm-sized HCC lesion in liver S8. Fourteen months thereafter, despite lack of intrahepatic recurrence, a single new 26-mm-sized mass was found in S10 of the right lung. The patient underwent right lower lobectomy. The histopathological diagnosis was HCC metastasis. Because no residual disease could be found, she was followed up without any additional treatment after surgery. She remains alive with no signs of recurrence 3 years later.

CONCLUSION

HCC patients who relapse with lung metastases but without intrahepatic recurrence after RFA are extremely rare, especially when RFA is used to treat HCC lesions <30 mm. However, it should be noted that, although rare, HCC may recur in the form of extrahepatic metastases after RFA. Furthermore, it is suggested that, as in the presently-described case, at least some patients without intrahepatic recurrence whose lung metastases are completely resected have a good prognosis even without additional treatment for HCC.

摘要

引言

肝细胞癌(HCC)经射频消融(RFA)后出现单一远处转移罕见。对于切除肺转移灶后无肝肿瘤的患者,尚无治疗指南。

病例介绍

在此,我们报告1例患者,RFA治疗14个月后HCC复发为单一肺转移。1例76岁女性,原发性胆汁性胆管炎,无乙肝病毒或丙肝病毒感染,因肝脏S8区一个16mm大小的HCC病灶接受RFA治疗。14个月后,尽管无肝内复发,但在右肺S10区发现一个新的26mm大小的肿块。患者接受右下叶切除术。组织病理学诊断为HCC转移。因未发现残留病灶,术后未进行任何额外治疗,对其进行随访。3年后她仍存活,无复发迹象。

结论

RFA治疗后出现肺转移但无肝内复发的HCC患者极为罕见,尤其是RFA用于治疗<30mm的HCC病灶时。然而,应注意的是,尽管罕见,但RFA后HCC可能以肝外转移的形式复发。此外,如本病例所示,至少部分无肝内复发且肺转移灶完全切除的患者,即使未接受HCC的额外治疗,预后也良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd9/10907002/4395b8184015/cro-2024-0017-0001-536498_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd9/10907002/e9829f3a087a/cro-2024-0017-0001-536498_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd9/10907002/231f216e12b9/cro-2024-0017-0001-536498_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd9/10907002/4395b8184015/cro-2024-0017-0001-536498_F03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd9/10907002/e9829f3a087a/cro-2024-0017-0001-536498_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd9/10907002/231f216e12b9/cro-2024-0017-0001-536498_F02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbd9/10907002/4395b8184015/cro-2024-0017-0001-536498_F03.jpg

相似文献

1
Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma.肝细胞癌射频消融术后肺转移瘤切除术
Case Rep Oncol. 2024 Mar 1;17(1):407-416. doi: 10.1159/000536498. eCollection 2024 Jan-Dec.
2
Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.射频消融治疗 HCC 肺转移瘤的有效性和安全性:一项五年研究。
Med Oncol. 2020 Mar 12;37(4):25. doi: 10.1007/s12032-020-01352-2.
3
[Pulmonary Metastases of Hepatocellular Carcinoma Treated with Repeated Pulmonary Resection-A Case Report].[重复肺切除治疗肝细胞癌肺转移——病例报告]
Gan To Kagaku Ryoho. 2019 Dec;46(13):2527-2529.
4
Intrahepatic bile duct recurrence of hepatocellular carcinoma without a detectable liver tumor.肝细胞癌肝内胆管复发且无可检测到的肝脏肿瘤。
Int J Surg Case Rep. 2012;3(7):275-8. doi: 10.1016/j.ijscr.2012.03.017. Epub 2012 Mar 28.
5
Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C.丙型肝炎患者肝细胞癌射频消融术后肝细胞癌复发的危险因素
World J Gastroenterol. 2005 Apr 14;11(14):2174-8. doi: 10.3748/wjg.v11.i14.2174.
6
Detection of needle tract implantation and peritoneal seeding after radiofrequency ablation using intraoperative near-infrared fluorescence system for recurrent hepatocellular carcinoma: a case report.使用术中近红外荧光系统检测复发性肝细胞癌射频消融术后针道种植和腹膜种植:一例报告
Surg Case Rep. 2018 Jul 13;4(1):76. doi: 10.1186/s40792-018-0485-5.
7
No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.无接触式多点射频消融与手术切除治疗 2-5cm 单发肝细胞癌的比较。
J Hepatol. 2018 Jun;68(6):1172-1180. doi: 10.1016/j.jhep.2018.01.014. Epub 2018 Feb 2.
8
Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery.射频消融治疗后复发性肝细胞癌的临床病理特征及挽救性手术治疗。
Hepatol Res. 2014 Oct;44(11):1062-71. doi: 10.1111/hepr.12223. Epub 2013 Sep 18.
9
Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.肝细胞癌射频消融术后复发模式及其对生存结局的影响分析
J Gastrointest Surg. 2008 Jan;12(1):183-91. doi: 10.1007/s11605-007-0276-y. Epub 2007 Sep 15.
10
Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience.经皮射频消融治疗肝移植后肝内复发性肝细胞癌的可行性和疗效:单中心经验。
Int J Hyperthermia. 2020;37(1):1202-1209. doi: 10.1080/02656736.2020.1834154.

本文引用的文献

1
Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update.经动脉化疗栓塞联合全身治疗肝细胞癌:最新进展
J Pers Med. 2022 Oct 29;12(11):1788. doi: 10.3390/jpm12111788.
2
Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 20-04).立体定向消融放疗治疗寡转移性肝细胞癌:一项多机构回顾性研究(KROG 20-04)
Cancers (Basel). 2022 Nov 27;14(23):5848. doi: 10.3390/cancers14235848.
3
Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial).
手术与射频消融治疗小肝癌:一项随机对照试验(SURF试验)。
Liver Cancer. 2021 Dec 29;11(3):209-218. doi: 10.1159/000521665. eCollection 2022 Jun.
4
Atezolizumab in advanced hepatocellular carcinoma: good things come to those who wait.阿替利珠单抗治疗晚期肝细胞癌:好事多磨。
Immunotherapy. 2021 Jun;13(8):637-644. doi: 10.2217/imt-2021-0026. Epub 2021 Apr 6.
5
Efficacy of Local Therapy for Oligometastatic Hepatocellular Carcinoma: A Propensity Score Matched Analysis.寡转移性肝细胞癌局部治疗的疗效:一项倾向评分匹配分析
J Hepatocell Carcinoma. 2021 Feb 11;8:35-44. doi: 10.2147/JHC.S290197. eCollection 2021.
6
Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma.消融性放疗改善肝癌骨转移患者的肿瘤学结局。
J Cancer Res Clin Oncol. 2021 Sep;147(9):2693-2700. doi: 10.1007/s00432-021-03553-2. Epub 2021 Feb 13.
7
Systemic adjuvant treatment in hepatocellular carcinoma: tempted to do something rather than nothing.肝细胞癌的全身辅助治疗:倾向于采取行动而非无所作为。
Future Oncol. 2020 Nov;16(32):2587-2589. doi: 10.2217/fon-2020-0669. Epub 2020 Aug 8.
8
IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation.IMbrave 050:阿替利珠单抗联合贝伐珠单抗用于根治性切除或消融治疗后高危肝细胞癌的 III 期临床试验。
Future Oncol. 2020 May;16(15):975-989. doi: 10.2217/fon-2020-0162. Epub 2020 Apr 30.
9
Clinical Factors Predictive of a Better Prognosis of Pulmonary Metastasectomy for Hepatocellular Carcinoma.临床因素预测肝癌肺转移切除术的预后更好。
Ann Thorac Surg. 2019 Dec;108(6):1685-1691. doi: 10.1016/j.athoracsur.2019.06.086. Epub 2019 Aug 21.
10
Three risk factors for pulmonary metastasectomy in patients with hepatocellular carcinoma.肝细胞癌患者肺转移瘤切除术的三个危险因素。
Gen Thorac Cardiovasc Surg. 2019 Sep;67(9):782-787. doi: 10.1007/s11748-019-01082-x. Epub 2019 Feb 28.